Analysed FATE THERAPEUTICS INC (FATE:NASDAQ) News Sources
Fate Therapeutics Announces Data Presentation of FT839 Next-Generation Off-The-Shelf CAR T-Cell Product Candidate for the Broad Treatment of Hematological Malignancies and Autoimmune Diseases Without the Need for Conditioning Chemotherapy at the AACR Annual Meeting
16-04-2026
yahoo.com
Fate Therapeutics Details Off-the-Shelf CAR T Progress in Lupus and Solid Tumors at Needham Conference
16-04-2026
marketbeat.com
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
02-04-2026
yahoo.com
Fate Therapeutics Details FT819 CAR T Manufacturing and Phase II Lupus Trial Plans at Conference
16-03-2026
marketbeat.com
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
04-03-2026
yahoo.com
Fate Therapeutics to Participate in Leerink Partners 2026 Global Healthcare Conference
03-03-2026
yahoo.com
What is the current price of FATE THERAPEUTICS INC (FATE:NASDAQ)?
The current price of FATE THERAPEUTICS INC (FATE:NASDAQ) is $1.35.
FATE THERAPEUTICS INC (FATE:NASDAQ) absolute price change since previous trading day?
The absolute price change of FATE THERAPEUTICS INC (FATE:NASDAQ) since the previous trading day is $-0.04.
FATE THERAPEUTICS INC (FATE:NASDAQ) percentage price change since previous trading day?
The percentage price change of FATE THERAPEUTICS INC (FATE:NASDAQ) since the previous trading day is -2.8777%.
What is the most recent average sentiment score for FATE THERAPEUTICS INC (FATE:NASDAQ)?
The most recent average sentiment score for FATE THERAPEUTICS INC (FATE:NASDAQ) is 89 out of 100.
What is the most recent average sentiment for FATE THERAPEUTICS INC (FATE:NASDAQ)?
The most recent sentiment for FATE THERAPEUTICS INC (FATE:NASDAQ) is .
SEC-8K** Filing Available For FATE THERAPEUTICS INC (FATE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.